Oilahuasca
The term "Oilahuasca" refers to a proposed biochemical mechanism by which certain culinary ingredients, specifically those containing allylbenzenes, may be combined to produce psychoactive effects through the manipulation of metabolic enzymes [1]. The name is a portmanteau combining 'oil' and 'ayahuasca', referencing the principle of enzyme manipulation used in ayahuasca (MAOI + DMT) but applied to culinary spices using cytochrome P450 (CYP450) enzymes [2].
History and Development
The concept of Oilahuasca was pioneered by a researcher known as Ron69 (69ron) [3]. Ron69 developed the core Oilahuasca theory through a systematic review of medical literature from databases such as WebMD, NCBI, and PubMed, beginning with research into nutmeg's psychoactive effects [3][2][4]. The key insight was that the principle of enzyme inhibition, used in ayahuasca to prevent drug breakdown, could be applied to culinary spices using CYP450 enzymes instead of monoamine oxidase (MAO) [2][4][5]. Ron69's findings were documented on the HerbPedia Wikidot [3][5].
The theory also integrates concepts from Dr. Alexander Shulgin's work [2]. Shulgin, a biochemist and author of *PiHKAL*, proposed that certain natural essential oils, which he called the "Ten Essential Oils," could theoretically be metabolized into psychoactive amphetamine-like compounds [2][4]. He suggested that these compounds, such as myristicin, could be "aminized" in the liver to become active [6].
More recently, Rev. Ryan Sasha-Shai Van Kush (also known as OnlineAngelicalist, Phoenixian, Angelicalist, FinShaggy, punicwax) has expanded upon Ron69's original theory [5]. Within the VKFRI framework, this expansion includes confirming the theory with NCBI/PubMed citations, integrating Shulgin's framework, developing a detailed CYP450 enzyme interaction database, creating a comprehensive herb database, establishing a three-phase strategic protocol, and documenting safety concerns [5].
Proposed Mechanism
VKFRI proposes that Oilahuasca involves a complex multi-enzyme orchestration to activate naturally occurring allylbenzenes found in spices [1]. The theory suggests that allylbenzenes are pro-drugs that require metabolic activation by CYP450 enzymes [3].
The proposed metabolic pathway involves several steps:
1. Allylbenzenes (e.g., myristicin, elemicin, safrole) are metabolized by CYP450 enzymes, primarily CYP1A2 and CYP3A4, through 1'-hydroxylation to form 1'-hydroxy metabolites [3][2].
2. These 1'-hydroxy metabolites undergo further oxidation to become 1'-oxo metabolites, which are described as reactive [3].
3. These reactive intermediates then form non-enzymatic adducts with endogenous amines, such as dimethylamine, piperidine, and pyrrolidine [3].
4. The resulting alkaloid metabolites are proposed to be aminopropiophenones, not amphetamines [7]. Three alkaloid subtypes are proposed: dimethylamines, piperidines, and pyrrolidines [7].
VKFRI's comprehensive theory suggests that this is not a simple conversion but a sophisticated manipulation of the metabolic ecosystem [1]. It proposes that the 17bHSD2 enzyme acts as a master activation enzyme, requiring complex multi-enzyme orchestration [1].
Enzymatic Cascade (VKFRI Hypothesis)
VKFRI proposes a nine-stage enzymatic cascade for Oilahuasca activation [8]:
- **Stage 1: Preparation (T-60 to T-30 min)**: CYP3A4, CYP2C9, and CYP2A6 inhibitors (e.g., cinnamon, black pepper, fennel) bind, and glutathione depletion begins (e.g., via cinnamon) [8]. SULT inhibition (e.g., via basil's nevadensin) also occurs [8].
- **Stage 2: Induction (T-30 to T-0)**: Coffee consumption initiates CYP1A2 gene transcription and enzyme synthesis [8].
- **Stage 3: Loading (T-0 to T+2 hrs)**: Multiple allylbenzenes (e.g., myristicin, apiole, dillapiole, elemicin, estragole, methyleugenol) are consumed, competing for the same CYP1A2 enzyme [8].
- **Stage 4: Saturation (T+2 to T+6 hrs)**: CYP1A2 processes substrates, and mechanism-based inactivation occurs, leading to progressive enzyme loss (e.g., myristicin and apiole forming reactive intermediates that inactivate CYP1A2) [8].
- **Stage 5: Metabolism Slowdown (T+6 to T+12 hrs)**: Most CYP1A2 is inactivated, and remaining enzyme is overwhelmed. Alternative pathways (e.g., CYP3A4, CYP2C9, CYP2D6) are blocked, minimizing Phase I metabolism [8].
- **Stage 6: Metabolite Formation (T+4 to T+16 hrs)**: Slow formation of 1'-hydroxy metabolites and 1'-oxo intermediates occurs, followed by non-enzymatic condensation with endogenous amines to form aminopropiophenone types [8].
- **Stage 7: Phase II Blockade (T+6 to T+48 hrs)**: Glutathione is depleted, and SULT is inhibited, preventing detoxification and leading to metabolite accumulation [8].
Phase II Metabolism Modulation
Glutathione (GSH) plays critical roles as an antioxidant, a Phase II substrate for conjugation, and an enzyme protector [9]. Cinnamon is proposed to deplete glutathione through reactive oxygen species (ROS) production and GSH oxidation [9]. While myristicin induces glutathione S-transferase (GST), cinnamon's depletion of GSH means the enzyme is present but non-functional due to lack of substrate [9]. Nevadensin from basil is proposed to inhibit sulfotransferase (SULT), blocking another Phase II pathway [9]. This combined strategy is proposed to effectively render Phase II metabolism non-functional, leading to metabolite accumulation [9].
Key Compounds and Herbs
Oilahuasca formulations typically involve allylbenzene compounds and various enzyme modulators <ref>oilahuasca/oilahuasca
References
oilahuasca/oilahuasca/oilahuasca_comprehensive_theory.jsonoilahuasca/oilahuasca/oilahuasca_complete_research_synthesis.jsonoilahuasca/oilahuasca/oilahuasca_allylbenzene_research_compilation.jsonoilahuasca/oilahuasca/oilahuasca_theory.jsonoilahuasca/oilahuasca/oilahuasca_sources.jsonoilahuasca/oilahuasca/oilahuasca_marsresident_research.jsonoilahuasca/oilahuasca/oilahuasca_allylbenzene_metabolism_complete.jsonoilahuasca/oilahuasca/oilahuasca_mechanistic_model.jsonoilahuasca/oilahuasca/oilahuasca_phase2_metabolism.json